Selection of TB Medicines and Supplies - PowerPoint PPT Presentation

Selection of tb medicines and supplies
1 / 22

  • Uploaded on
  • Presentation posted in: General

Selection of TB Medicines and Supplies. Unit Objective. Understand basic principles of selection of appropriate formulations of essential tuberculosis medicines . QUAN 1. Selection. Management. Procurement. Use. Support. Distribution. Policy and Legal Framework.

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.

Download Presentation

Selection of TB Medicines and Supplies

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript

Selection of tb medicines and supplies

Selection of TB Medicines and Supplies

Unit objective

Unit Objective

Understand basic principles of selection of appropriate formulations of essential tuberculosis medicines


Pharmaceutical management cycle







Policy and Legal Framework

Pharmaceutical Management Cycle

Considerations for tb drug selection

Considerations for TB Drug Selection

  • Epidemiological profile (category I II III MDR mix: morbidity, drug resistance)

  • Evidence-based medicine

  • Bio-equivalence /Bio-availability

  • National Treatment Guidelines / Regimens for first-line and second-line therapies (patient treatment kits)

  • Drug formulations (tablets, fixed-dose combination tablets soluble tablets, powder in sachets)

  • Marketing approval/registration

  • Applied pharmaco-economics:

    • the most cost effective TB treatment = DOTS

    • Costs of different drugs, availability, delivery times

Medicine selection process

Medicine Selection Process

  • Review patterns of TB morbidity, drug resistance, and populations affected

  • Identify standard treatments in the TB program (e.g. DOTS regimens)

  • Develop a list of essential medicines and supplies to standardize drug availability: specify medicine, generic name, strength, dosage form and familiarity of health worker at treatment centers

  • Select specific 1st-line TB medicines

  • Select specific 2nd-line medicines for drug-resistant TB

Advantages of selecting appropriate medicine formulations

Advantages of Selecting Appropriate Medicine Formulations

  • Controls prescribing habits (prevention of MDR-TB, controls limited resources)

  • Facilitates better purchase prices: — fewer number of products, economies of scale

  • Simplifies management of supplies and stock

  • Financial: short and long term savings and cost control

  • Improve treatment outcome

Selecting 1st line medicines 1

Selecting 1st-line Medicines (1)

WHO-recommended formulations: anti-tuberculosis drugs

  • Separate drugs / Active ingredients

    • Rifampicin *(R) tablet / capsule, 150 mg, 300 mg

    • Isoniazid(H) tablet 100 mg, 300 mg

    • Pyrazinamide(Z) tablet 400 mg

    • Ethambutol (E) tablet 100 mg, 400 mg

    • Streptomycin(S) vial, 1 gr

      * Only as (FDCs); single formulations under special circumstances; develops resistance easily

      Note: thioacetazone (T) is discouraged by WHO: risk of severe toxicity, in HIV infected individuals

Selecting 1st line medicines 2

Selecting 1st-line Medicines (2)

WHO-recommended formulations: anti-tuberculosis drugs

Fixed-dose combinations of drugs (adult doses)

  • 4-FDCRHZEtablet R150/H75/Z400/E275

  • 3-FDCRHZtablet R150/H75/Z400

  • 2-FDCRHtablet R150/H75; (R300/H150); R150/H150

  • 2-FDCEHtablet E400/H150

    Note: all in black are available from the GDF

Source: WHO. 2003. Treatment of Tuberculosis. Guidelines for National Programmes Geneva: WHO.

Selecting 1st line medicines 3

Selecting 1st-line Medicines (3)

WHO-recommended formulations: anti-tuberculosis drugs

Fixed-dose combinations of drugs (pediatric treatment)

  • 3-FDCRHZR60/H30/Z150

  • 2-FDCRHR60/H30

  • 2-FDCRHR60/H60

    (all are soluble tablets/granules)

    Note: all will be available from the GDF shortly

Source: WHO. 2003. Treatment of Tuberculosis. Guidelines for National Programmes Geneva: WHO.

Selecting 1st line medicines 4

Selecting 1st-line Medicines (4)

Using fixed-dose combinations (FDC)

  • Advantages of FDCs

    • simplifies dose calculations, procurement and supply

    • provides patient with fewer tablets to swallow and provider to administer

    • reduces the risk of promoting drug-resistant TB / avoiding mono-therapy

    • H + R: 4 months continuation phase of treatment

    • H + E: useful: can be self-administered during the second phase but: may be less effective than H+R and extends treatment with extra 2 months!

Selecting 1st line medicines 5

Selecting 1st-line Medicines (5)

  • Cautions when using FDCs

    • Need demonstration of bioavailability (particularly for rifampicin) by independent labs

    • Need planning, coordination and training for initial switch-over and follow-on monitoring of treatment practices

    • Use of FDCs still require stocking of limited quantities of separate medicines for patients who experience adverse reactions (about 2%--WHO)

Selecting 1st line medicines 6

Selecting 1st-line Medicines (6)

Advantages of using patient kits (full treatment for one patient for 6-8 months)

  • Solidly promotes rational drug use, DOTS expansion and recording and reporting system

  • Simplifies drug management

    • quantification of needs (1 patient = 1 kit)

    • stock management and distribution

    • provider adherence to treatment standards

    • patient acceptability of treatment (ownership of kit and all required medicines are always available)

      Disadvantages of Kits

  • Need more storage space in warehouse, depot and health facility

  • Not suitable for large clinics: >100 patients p.d.

Selecting 2nd line medicines 1

Selecting 2nd-line Medicines (1)


  • Only do so after the country has a documented outbreak of multi-drug resistant (MDR) TB

  • Qualified specialists should make decisions for selecting 2nd-line medicines for the country, based on demonstrated drug-resistance patterns

  • Note: international recommendations and standard guidelines are still being developed

Selecting 2nd line medicines 11

WHO-recommended for MDR TB



Para-aminosalicylic acid







Selecting 2nd-line Medicines (1)

Characteristics of 2 nd line medicines

Characteristics of 2nd-line Medicines

  • Limited supplyNumber of suppliers

    • Capremycin 1 g. vialfew

    • Cylcoserine 250 mg tabletfew

    • Ethionamide 250 mg tabletmany

    • Kanamycin/amikacin 1 g. vialmany

    • Para-aminosalicylic acid 4 g. sachetfew

    • Ofloxacin/ciprofloxacin 200/250 mg tabletfew

  • More medicines are needed for longer periods of time (up to 24 months)

  • More expensive—can be 100 to 1000 times as expensive as 1st-line TB medicines

  • Not as effective

  • More toxic

Criteria for selecting 2 nd line medicines

Criteria for Selecting 2nd line Medicines

  • Possible regimens

    • Use only standardized protocol

      • Individualize if standardized fails

    • Use empiric protocols,

      • if fails then individualized

        (Note: Comparative effectiveness has not been determined for any of the regimens)

  • Registration in the country

  • Acquisition costs and longest possible expiry date

Cautions for 2 nd line medicines

Cautions for 2nd-line Medicines

  • Should not keep drugs in reserve—some have only 18 months shelf life

  • Using 2nd-line medicines incorrectly may seriously increase resistance to our “last-resort” TB treatment

Ancillary medicines for 2 nd line treatment managing adverse effects

Ancillary Medicines for 2nd line treatment: Managing Adverse Effects

Categories of Adverse Reactions

  • Minor side effects

  • Toxic reactions

  • Hypersensitivity reactions

  • Idiosyncratic reactions

  • Reactions not classified in any of the above

Ancillary medicines examples

Ancillary Medicines: Examples

  • Analgesics for headaches: aspirin, paracetamol

  • Anti-emetics: promethazine, metoclopramide

  • Anti-ulcer: anti-acids, ranitidine

  • Anti-fungal agents: fluconazole or clotrimazole

  • Anti-diarrheals: loperamide

  • Anti-depressants: amitriptyline, fluoxetine

  • Anti-convulsants: diazepam, phenytoin

  • Inhaled beclomethasone for bronchospasms

  • Epinephrine for systemic hypersensitivity reactions

Tb supplies examples

Water for injection

Needles and syringes

Disinfectants, soaps, towels, and tissues

Gloves and face masks

Sputum cups

Forms and labels

ZN stains and other chemicals


Resuscitation equipment


Filter and lens paper


Miscellaneous equipment for microscopy

Culture media, Petri plates

Autoclave, incubator, sterilizer


X-ray machine, film developer and fixer

TB Supplies - Examples

Management challenges 1

Management Challenges (1)

  • Authority to select TB medicines ?

    • NTP manager

    • NDRA

    • Essential drug committee

    • National Pharmacy Board

    • Private sector

Selection management challenges 2

Selection: Management Challenges (2)

  • Lack of quality TB drugs registered in the country

  • Pressure from manufacturers and suppliers

  • Branded versus generic drugs (non-informative brand names)

  • Local biases: schools of thought, personal interests

  • Lack of skills to use selected drugs (e.g., FDC)

  • Unjustified selection of second-line drugs

  • Login